Daily Flibanserin “Generally Safe” for Some Postmenopausal Women, Study Finds
Flibanserin, a drug used to treat low sexual desire, is “generally safe and well-tolerated” for both premenopausal and naturally postmenopausal women, according to trial results published in the Journal of Sexual Medicine. More specifically, the drug is designed to treat hypoactive sexual desire disorder (HSDD). Women with HSDD lose interest in sex for reasons that can’t be readily…CONTINUE READING
Do Orgasms Change Over Time?
Like many aspects of sex, orgasms are always changing. You might have one night of passion that feels like an out-of-body experience. You might have another that is pleasant, but not necessarily powerful. And you might have another that is just humdrum. Should you worry? Not necessarily. While it can be frustrating to see the intensity…CONTINUE READING
Effect of Linear Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction—12-Month Follow-Up of a Randomized, Double-Blinded, Sham-Controlled Study
Abstract: Introduction Short-term data on the effect of low-intensity extracorporeal shockwave therapy (Li-ESWT) on erectile dysfunction (ED) have been inconsistent. The suggested mechanisms of action of Li-ESWT on ED include stimulation of cell proliferation, tissue regeneration, and angiogenesis, which can be processes with a long generation time. Therefore, long-term data on the effect of Li-ESWT on…CONTINUE READING
Scientists Investigate Health Risks of Testosterone Replacement Therapy
New research suggests that men on testosterone replacement therapy (TRT) are not at higher risk for cardiovascular events or blood clots but might be more likely to have obstructive sleep apnea. Testosterone is important for men, as it is responsible for masculine features, such as facial hair and muscle mass. The hormone also drives a…CONTINUE READING